Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Saeger

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinical Medicine (London, England)|April 10, 2014
Lesson of the month (1): cabergoline - 'i eat funny on that'Vidath Sasanka Premaratne, Ivan Saeger, Bridget K Macdonald
Current Opinion in Neurobiology|October 5, 2013
Facial motor neuron migration advancesSarah J Wanner, Ivan Saeger, Sarah Guthrie, et al.
Addiction (Abingdon, England)|December 10, 2025
5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) for alcohol use disorder: An open-label, phase 2, proof-of-concept, clinical trialJohn Marsden, Michael Kelleher, Fiona Dunbar, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinical Medicine (London, England)|April 10, 2014
Lesson of the month (1): cabergoline - 'i eat funny on that'Vidath Sasanka Premaratne, Ivan Saeger, Bridget K Macdonald
Current Opinion in Neurobiology|October 5, 2013
Facial motor neuron migration advancesSarah J Wanner, Ivan Saeger, Sarah Guthrie, et al.
Addiction (Abingdon, England)|December 10, 2025
5-Methoxy-N,N-dimethyltryptamine (5-MeO-DMT) for alcohol use disorder: An open-label, phase 2, proof-of-concept, clinical trialJohn Marsden, Michael Kelleher, Fiona Dunbar, et al.
Pageof 1